-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Sarepta Therapeutics, Inc. quarterly/annual Current State and Local Tax Expense (Benefit) history and growth rate from 2017 to 2024.
- Sarepta Therapeutics, Inc. Current State and Local Tax Expense (Benefit) for the quarter ending December 31, 2023 was -$19.6M.
- Sarepta Therapeutics, Inc. Current State and Local Tax Expense (Benefit) for the twelve months ending December 31, 2023 was $11.1M.
- Sarepta Therapeutics, Inc. annual Current State and Local Tax Expense (Benefit) for 2024 was $19.7M, a 77.7% increase from 2023.
- Sarepta Therapeutics, Inc. annual Current State and Local Tax Expense (Benefit) for 2023 was $11.1M, a 15.8% decline from 2022.
- Sarepta Therapeutics, Inc. annual Current State and Local Tax Expense (Benefit) for 2022 was $13.2M.
Current State and Local Tax Expense (Benefit), Trailing 12 Months (USD)
Current State and Local Tax Expense (Benefit), Quarterly (USD)
Current State and Local Tax Expense (Benefit), Annual (USD)
Current State and Local Tax Expense (Benefit), YoY Annual Growth (%)